3 Results for "

IAPP aggregation

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "IAPP aggregation" in MCE Product Catalog:

Cat. No.: HY-P2392
CAS No.: 252554-79-3
Research Areas:  

Others

Fmoc-Ala-Thr (psi (Me,Me) pro)-OH is an Fmoc-protected pseudoproline derivative that serves as a building block for solid-phase peptide synthesis. Fmoc-Ala-Thr (psi (Me,Me) pro)-OH inhibits polypeptide aggregation and improves amino acid coupling efficiency during the synthesis of human and rat IAPP as well as general peptide synthesis. Fmoc-Ala-Thr (psi (Me,Me) pro)-OH is applicable to peptide synthesis-related research .
loading...
    loading...
Cat. No.: HY-182304
CAS No.: 1338489-62-5
CLR01 sodium is a blood-brain barrier-permeable anti-aggregation agent. CLR01 sodium inhibits the de novo aggregation of Amyloid-β 40/42, α-synuclein, IAPP, tau protein and SOD1. CLR01 sodium reduces amyloid plaque burden in the cortex of triple-transgenic mice and improves the memory and motor abilities of these mice. CLR01 sodium can be used in research related to Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) .
loading...
    loading...
Cat. No.: HY-P11899
Synonyms: Cyclo(VVIaWG)
Research Areas:  

Neurological Disease

Cyclo (Val-Val-Ile-d-Ala-Trp-Gly) (Cyclo(VVIaWG)) is a six-membered cyclic peptide designed based on the C-terminal region of Aβ1-42. Cyclo (Val-Val-Ile-d-Ala-Trp-Gly) binds selectively to Aβ15-36 (Kd = 0.6 μM), regulates the aggregation of Aβ1-42 at high concentrations, weakly inhibits fibrillation at a 10-fold excess, and inhibits oligomerization at equimolar concentrations. Cyclo (Val-Val-Ile-d-Ala-Trp-Gly) does not interfere with the aggregation of IAPP. Cyclo (Val-Val-Ile-d-Ala-Trp-Gly) can serve as a targeting ligand for fluorescent probes of Aβ prefibrillar aggregates, and is applicable to research related to Alzheimer's disease .
loading...
    loading...